Coronavirus could be the game changer that propels telemedicine into the mainstream. Virtual clinical services have been around since the ’90s but had failed to catch on. Now, a concerted effort by healthcare providers, insurance companies, the federal government, and individuals to manage the COVID-19 pandemic has put telemedicine at the frontline of healthcare. Telemedicine companies have seen their usage volumes surge this year, along with their stock prices.

To read this Market Insight, you’ll need to  sign in

If you don’t have a subscription,  sign up or start a free trial .